Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline S de Miranda

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Acta Neuropsychiatrica|June 13, 2025
Immunopsychiatry of late life depression: role of aging-related immune/inflammatory processes in the development and progression of depressionAntonio L Teixeira, Izabela G Barbosa, Moises E Bauer, et al.
Current Opinion in Psychiatry|July 25, 2025
Understanding late-life depression: focus on inflammationAntonio L Teixeira, Aline S de Miranda, Venugopal Reddy Venna, et al.
Current Neurovascular Research|August 22, 2020
Early Post-stroke Depressive Symptoms are Associated with Low Peripheral Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Glial Cell-derived Neurotrophic Factor (GDNF)Vinicius S P Pedroso, Érica L M Vieira, Aline S de Miranda, et al.
Journal of Psychiatric Research|April 16, 2018
Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulationJuliana R Bastos, Katherinne M Perico, Érica L Marciano Vieira, et al.
Current Medicinal Chemistry|March 14, 2018
Neurotrophic Factors in Parkinson's Disease: What Have we Learned from Pre-Clinical and Clinical Studies?Rodrigo N Ferreira, Aline S de Miranda, Natalia P Rocha, et al.
Critical Care (London, England)|June 3, 2014
Inflammation biomarkers and delirium in critically ill patientsCristiane Ritter, Cristiane D Tomasi, Felipe Dal-Pizzol, et al.
Neuropharmacology|November 6, 2022
TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampusLia P Iglesias, Heliana B Fernandes, Aline S de Miranda, et al.
Epilepsy & Behavior : E&B|August 19, 2017
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levelsLuciano R Vilela, Isabel V Lima, Érica B Kunsch, et al.
Frontiers in Neuroscience|March 1, 2021
Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating BehaviorTadeu P D Oliveira, Bruno D C Gonçalves, Bruna S Oliveira, et al.
Scientific Reports|April 5, 2022
Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington's diseaseRebeca P M Santos, Roberta Ribeiro, Talita H Ferreira-Vieira, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Neuropsychiatrica|June 13, 2025
Immunopsychiatry of late life depression: role of aging-related immune/inflammatory processes in the development and progression of depressionAntonio L Teixeira, Izabela G Barbosa, Moises E Bauer, et al.
Current Opinion in Psychiatry|July 25, 2025
Understanding late-life depression: focus on inflammationAntonio L Teixeira, Aline S de Miranda, Venugopal Reddy Venna, et al.
Current Neurovascular Research|August 22, 2020
Early Post-stroke Depressive Symptoms are Associated with Low Peripheral Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Glial Cell-derived Neurotrophic Factor (GDNF)Vinicius S P Pedroso, Érica L M Vieira, Aline S de Miranda, et al.
Journal of Psychiatric Research|April 16, 2018
Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulationJuliana R Bastos, Katherinne M Perico, Érica L Marciano Vieira, et al.
Current Medicinal Chemistry|March 14, 2018
Neurotrophic Factors in Parkinson's Disease: What Have we Learned from Pre-Clinical and Clinical Studies?Rodrigo N Ferreira, Aline S de Miranda, Natalia P Rocha, et al.
Critical Care (London, England)|June 3, 2014
Inflammation biomarkers and delirium in critically ill patientsCristiane Ritter, Cristiane D Tomasi, Felipe Dal-Pizzol, et al.
Neuropharmacology|November 6, 2022
TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampusLia P Iglesias, Heliana B Fernandes, Aline S de Miranda, et al.
Epilepsy & Behavior : E&B|August 19, 2017
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levelsLuciano R Vilela, Isabel V Lima, Érica B Kunsch, et al.
Frontiers in Neuroscience|March 1, 2021
Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating BehaviorTadeu P D Oliveira, Bruno D C Gonçalves, Bruna S Oliveira, et al.
Scientific Reports|April 5, 2022
Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington's diseaseRebeca P M Santos, Roberta Ribeiro, Talita H Ferreira-Vieira, et al.
Pageof 2